Predicting Nomogram for Severe Oral Mucositis in Patients with Nasopharyngeal Carcinoma During Intensity-Modulated Radiation Therapy: A Retrospective Cohort Study

Overview

Journal Curr Oncol

Publisher MDPI

Specialty Oncology

Date 2023 Jan 20

PMID 36661666

Authors

Zhibing Liu

Lulu Huang

Housheng Wang

Zhiling Shi

Yaqin Huang

Lixing Liang

RenSheng Wang

Kai Hu

Affiliations

Soon will be listed here.

Abstract

Background: Oral mucositis is an acute adverse reaction with high incidence during radiotherapy. Severe oral mucositis can seriously affect patients' quality of life and compliance with radiotherapy. The aim of this study was to identify the risk factors for severe oral mucositis and to develop a nomogram for predicting severe oral mucositis in patients with nasopharyngeal carcinoma.

Methods: One hundred and ninety patients with nasopharyngeal carcinoma were retrospectively screened in this study. Least absolute shrinkage and selection operator regression and multivariate logistic regression analyses were performed to identify the best predictors of severe oral mucositis. A nomogram was constructed based on the factors. Finally, the discriminative ability of the nomogram was evaluated.

Results: Four independent factors predicting severe oral mucositis were identified: age, N stage, the cycle of induction chemotherapy, and dose-volumetric parameter V40 (%) of oral cavity. The area under the receiver of operating characteristic curve of the nomogram was 0.759 (95% confidence interval: 0.691-0.827).

Conclusions: A predictive nomogram for severe oral mucositis was established and validated in this study. The nomogram provides a reliable and practical model for clinically predicting the probability of severe oral mucositis in patients with nasopharyngeal carcinoma before intensity-modulated radiation therapy.

Citing Articles

Improved Efficacy of a Predictive Model for Swallowing-Induced Breakthrough Pain Based on a Redefined Delineation Method in Locally Advanced Nasopharyngeal Carcinoma.

Sun J, Chen Z, Liu S, Ye F, Tang T, Zhou Z Adv Radiat Oncol. 2025; 10(2):101690.

PMID: 39871950 PMC: 11770509. DOI: 10.1016/j.adro.2024.101690.

Machine learning prediction model for oral mucositis risk in head and neck radiotherapy: a preliminary study.

Kauark-Fontes E, Araujo A, Andrade D, Faria K, Prado-Ribeiro A, Laheij A Support Care Cancer. 2025; 33(2):96.

PMID: 39808310 DOI: 10.1007/s00520-025-09158-6.

A multi-center, multi-organ, multi-omic prediction model for treatment-induced severe oral mucositis in nasopharyngeal carcinoma.

Nicol A, Lam S, Ching J, Tam V, Teng X, Zhang J Radiol Med. 2024; 130(2):161-178.

PMID: 39570458 PMC: 11870888. DOI: 10.1007/s11547-024-01901-z.

Adverse drug reactions and drug-related problems with supportive care medications among the oncological population.

Tajani B, Maheswari E, Maka V, Nair A Discov Oncol. 2024; 15(1):416.

PMID: 39249610 PMC: 11383904. DOI: 10.1007/s12672-024-01300-w.

Effect of modified Baduanjin exercise on nutritional status in patients with nasopharyngeal carcinoma: a randomized controlled trial.

Zhou S, Zhang Y, Yang G, Huang X, Li W, Lu J Support Care Cancer. 2024; 32(8):498.

PMID: 38981883 DOI: 10.1007/s00520-024-08646-5.

References

Vokurka S, Bystricka E, Koza V, Scudlova J, Pavlicova V, Valentova D . Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study. Support Care Cancer. 2006; 14(9):974-6. DOI: 10.1007/s00520-006-0031-z. View

Pulito C, Mori F, Sacconi A, Casadei L, Ferraiuolo M, Valerio M . Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion. Oncotarget. 2015; 6(20):18134-50. PMC: 4627240. DOI: 10.18632/oncotarget.4017. View

Chen X, Yao L, Shan Q, Qian X, Lu X, Tang X . Risk factors for oral mucositis in patients with malignant tumors: a prospective cohort study. Ann Palliat Med. 2021; 10(7):8180-8189. DOI: 10.21037/apm-21-1675. View

Soutome S, Yanamoto S, Nishii M, Kojima Y, Hasegawa T, Funahara M . Risk factors for severe radiation-induced oral mucositis in patients with oral cancer. J Dent Sci. 2021; 16(4):1241-1246. PMC: 8403800. DOI: 10.1016/j.jds.2021.01.009. View

Au K, Ngan R, Ng A, Poon D, Ng W, Yuen K . Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study). Oral Oncol. 2018; 77:16-21. DOI: 10.1016/j.oraloncology.2017.12.004. View

Bossi P, Locati L, Licitra L . Palifermin in prevention of head and neck cancer radiation-induced mucositis: not yet a definitive word on safety and efficacy profile. J Clin Oncol. 2012; 30(5):564-5. DOI: 10.1200/JCO.2011.39.1136. View

Rabinovitch R, Grant B, Berkey B, Raben D, Ang K, Fu K . Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03. Head Neck. 2005; 28(4):287-96. DOI: 10.1002/hed.20335. View

Zhu X, Yang X, Chao Y, Zheng H, Sheng H, Liu H . The Potential Effect of Oral Microbiota in the Prediction of Mucositis During Radiotherapy for Nasopharyngeal Carcinoma. EBioMedicine. 2017; 18:23-31. PMC: 5405060. DOI: 10.1016/j.ebiom.2017.02.002. View

You R, Hua Y, Liu Y, Yang Q, Zhang Y, Li J . Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up. Theranostics. 2017; 7(8):2314-2324. PMC: 5505063. DOI: 10.7150/thno.19710. View

10.

Pico , Naccache . Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology Setting. Oncologist. 1999; 3(6):446-451. View

11.

Haddad R, ONeill A, Rabinowits G, Tishler R, Khuri F, Adkins D . Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol. 2013; 14(3):257-64. DOI: 10.1016/S1470-2045(13)70011-1. View

12.

Carli E, Pasini M, Lardani L, Giuca G, Miceli M . Impact of self-ligating orthodontic brackets on dental biofilm and periodontal pathogens in adolescents. J Biol Regul Homeost Agents. 2021; 35(3 Suppl. 1):107-115. DOI: 10.23812/21-3supp1-13. View

13.

Li W, Chen N, Zhang N, Hu G, Xie F, Sun Y . Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial. Int J Cancer. 2019; 145(1):295-305. DOI: 10.1002/ijc.32099. View

14.

Peterson D, Bensadoun R, Roila F . Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol. 2011; 22 Suppl 6:vi78-84. PMC: 3662500. DOI: 10.1093/annonc/mdr391. View

15.

You R, Sun R, Hua Y, Li C, Li J, Zou X . Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma. Int J Cancer. 2017; 141(6):1265-1276. DOI: 10.1002/ijc.30819. View

16.

Zhang Y, Chen L, Hu G, Zhang N, Zhu X, Yang K . Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma. N Engl J Med. 2019; 381(12):1124-1135. DOI: 10.1056/NEJMoa1905287. View

17.

Lancellotta V, Pagano S, Tagliaferri L, Piergentini M, Ricci A, Montecchiani S . Individual 3-dimensional printed mold for treating hard palate carcinoma with brachytherapy: A clinical report. J Prosthet Dent. 2018; 121(4):690-693. DOI: 10.1016/j.prosdent.2018.06.016. View

18.

Hou J, Zheng H, Li P, Liu H, Zhou H, Yang X . Distinct shifts in the oral microbiota are associated with the progression and aggravation of mucositis during radiotherapy. Radiother Oncol. 2018; 129(1):44-51. DOI: 10.1016/j.radonc.2018.04.023. View

19.

Mai H, Chen Q, Chen D, Hu C, Yang K, Wen J . Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial. Nat Med. 2021; 27(9):1536-1543. DOI: 10.1038/s41591-021-01444-0. View

20.

Wu F, Wang R, Lu H, Wei B, Feng G, Li G . Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study. Radiother Oncol. 2014; 112(1):106-11. DOI: 10.1016/j.radonc.2014.05.005. View